NCT03424226View on ClinicalTrials.gov

Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages

PHASE1CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 4, 2018

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Acute Mountain Sickness
Interventions
DRUG

Acetazolamide

a diuretic and commonly used medication for prevention and treatment of acute mountain sickness

Trial Locations (1)

94305

Stanford University, Stanford

All Listed Sponsors
lead

Stanford University

OTHER

NCT03424226 - Sickness Evaluation at Altitude With Acetazolamide at Relative Dosages | Biotech Hunter | Biotech Hunter